Novartis CEO: We’re Moving Toward Filing Covid Drug From Molecular Partners With FDA
Following is the unofficial transcript of a CNBC exclusive interview with Novartis (NYSE:NVS) CEO Dr. Vas Narasimhan on CNBC’s “Squawk on the Street” (M-F 9AM – 11AM ET) today, Wednesday, January 12. Following is a link to video on CNBC.com: Q4 2021 hedge fund letters, conferences and more Novartis CEO: We’re Moving Toward Filing Covid Drug From Molecular Partners With FDACARL QUINTANILLA: Day three of the JPMorgan Healthcare Conference. Meg Tirrell joins us with a special guest. Hey Meg. MEG TIRRELL: Hey Carl. Dr. Vas Narasimhan, the CEO of Novartis, joins us now. Vas, it’s great to see you. ...